Ireland’s EU drug-buying partnership secures first deal
The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy
The European partnership that aims to jointly negotiate pharmaceutical deals has reached its first collective pricing agreement.
The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy.
Spinraza is already being funded by the HSE in Ireland.
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply